Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Darolutamide + ADT for Metastatic Hormone-Sensitive Prostate Cancer
Recruiting1 awardPhase 2
Ann Arbor, Michigan
This trial will test if adding darolutamide to ADT will be more effective than ADT alone in men with hormone-sensitive prostate cancer that has spread to other parts of the body.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service